2021 in Review
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
56 Results
Clear Filters
Translating Discoveries into Medicine, Advancing Equity in Science, and New Cancer Therapies: Watch Highlights of the 2021 NYSCF Conference
On October 19th and 20th, we hosted the sixteenth annual NYSCF Conference on translational stem cell research. This year’s meeting, held virtually for the second consecutive...
The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
Bringing Creative Flair to Stem Cell Research: Meet Kay Unger
NYSCF Board Member Kay Unger may be best known for her eponymous brand and trailblazing career in fashion, but she’s also an inspiring advocate for biomedical...
Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Organoids Just Gained Their Missing Ingredient: Functional Blood Vessels
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Using Stem Cells and Gene Editing to Fight Neonatal Diabetes
The Context: Neonatal diabetes affects between 1 and 5 percent of all diabetes patients. It is caused by a single genetic mutation that prevents pancreatic beta...
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NYSCF and Lyfebulb Announce Collaboration on Chronic Disease Research and Education
Lyfebulb, a patient-empowerment platform that connects chronic disease patients, industry, and investors to empower patients and support user-driven innovation, and The New York Stem Cell Foundation...
Four NYSCF Innovators Featured In Nature Article on Embryonic Stem Cell Research
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Cutting-Edge Research Highlights The NYSCF Conference
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF Innovator Makes Step Towards Therapies for Metabolic Diseases
NYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a...
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
The Wall Street Journal Profiles NYSCF CEO and Co-Founder Susan L. Solomon
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
NYSCF 10th Annual Conference: Two Nobel Laureates to Chair and Participate on Panels
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF Announces 2014 Class of NYSCF – Druckenmiller Fellows
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
SCNT – Susan Solomon and Dr. Dieter Egli Discuss NYSCF’s Latest Breakthrough
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon.
First Disease-Specific Stem Cell Line by SCNT
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
Stem Cell Search
The NYSCF Research Institute makes stem cell lines available through its stem cell repository. To search for specific cell lines, a specialized stem cell search interface...
NYSCF Scientists Find Compound To Preserve Beta Cell Function in Diabetes Model
NYSCF scientists published a paper today in the journal Diabetes on a breakthrough in diabetes research that could lead to new therapeutic approaches for patients with a...